Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
ACETYLCHOLINESTERASE
Cell model
ARN
AAV
Knockout
Trinucleotide Repeat Expansion
Endurance training
Expression
Dystrophie myotonique
Exercise
Antisense oligonucleotide
CRISPRi
Dystrophie Myotonique
Fibrosis
Centronuclear myopathy
Brain dysfunction
Muscular dystrophy
Mouse models
Acute coronary syndrome
PacBio
Myotonic Dystrophy Type 1
CTG repeats
Myotonic dystrophy type 1
Gene editing
Muscle
GSK3
Exercice
RNA interference
Trinucleotide repeat expansion
Glucocorticoid-receptor
Brain
Transcriptomics
DM1
Cardiac muscle
Therapy
Myotonic Dystrophy type 1
Intermediate filament
Oligodendrocyte
Motoneuron
Cytoskeleton
CRISPR/Cas9
Myotonic dystrophy mouse models
Dystrophin
DMSXL mice
CTG repeat contractions
Glucocorticoids
Glutamate
Male
Alternative splicing
Neuron
Transgenic mouse model
Dynamin 2
Heart failure
Mice
Animals
Myelin
Astrocyte
Diaphragm
Oligodendrocytes
Autophagy
CONGENITAL MYATHENIC SYNDROME
Acetylcholinesterase knockout mouse
Gene Therapy
RNA biology
Humans
Genotype phenotype correlation
PCR
BIOLOGIE MOLECULAIRE
Myotonic dystrophy
Quantitative microdialysis
Dilated cardiomyopathy
Transgenic mouse
Antisense oligonucleotides
Cell culture model
Heart
GABA
Cell penetrating peptide
Aging
Thérapie génique
Astrocytes
CTG repeat instability
Myostatin
DMPK
KNOCKOUT MICE
Myotonic Dystrophy
Gene therapy
Hypoxia
Glial cells
Skeletal muscle
Desmin
Duchenne muscular dystrophy
Long read sequencing
MBNL
Central nervous system
CMS
Maximal force
Mouse model
In vivo
Acetylcholinesterase deficiency
RNA splicing